|
Market Closed -
NSE India S.E.
07:05:09 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 191.45 INR | +1.47% |
|
+3.47% | +9.34% |
| Market Cap | 6.78B 70.61M 61.57M 58.14M 52.79M 98.92M 99.33M 696M 269M 3.44B 265M 259M 11.08B | P/E 2025 |
21.8x | P/E 2026 | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.98B 72.69M 63.39M 59.85M 54.35M 102M 102M 717M 277M 3.55B 273M 267M 11.41B | EV / Sales 2025 |
2.88x | EV / Sales 2026 | 1.98x |
| Free-Float |
28.24% | Yield 2025 * |
-
| Yield 2026 | - |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| KILITCH | Delayed | |
NSE India S.E.
| KILITCH | Delayed |
| 1 day | +1.47% | ||
| 1 week | +3.47% | ||
| Current month | +9.63% | ||
| 1 month | +10.93% | ||
| 3 months | +5.45% | ||
| 6 months | +19.84% | ||
| Current year | +9.34% |
| 1 week | 185 | 194 | |
| 1 month | 156 | 194 | |
| Current year | 117.25 | 207.77 | |
| 1 year | 117.25 | 219.5 | |
| 3 years | 111.78 | 250 | |
| 5 years | 62.5 | 250 | |
| 10 years | 16.15 | 250 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 73 | 1992-05-11 | |
| Director of Finance/CFO | 43 | 2021-02-28 | |
Tajouddin Ansari
COO | Chief Operating Officer | - | 2021-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | - | |
| Director/Board Member | 50 | 2007-09-28 | |
| Director/Board Member | 48 | 2014-09-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.47% | +3.47% | - | - | 69.76M | ||
| -0.83% | +2.45% | +49.83% | +100.09% | 1,027B | ||
| 0.00% | +1.55% | +54.86% | +66.00% | 651B | ||
| -0.01% | +2.66% | +18.90% | +71.46% | 467B | ||
| -1.22% | +3.66% | +36.44% | +38.32% | 350B | ||
| -0.79% | +2.73% | +19.03% | +25.08% | 268B | ||
| +0.58% | +6.76% | +11.13% | +16.52% | 257B | ||
| +0.78% | +1.44% | +38.78% | +45.46% | 205B | ||
| +0.79% | +1.84% | -28.27% | -56.71% | 190B | ||
| -0.12% | +4.70% | +32.43% | +98.98% | 187B | ||
| Average | +0.03% | +2.49% | +25.90% | +45.02% | 400.23B | |
| Weighted average by Cap. | -0.31% | +2.62% | +34.73% | +61.24% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.98B 20.67M 18.02M 17.02M 15.45M 28.95M 29.07M 204M 78.66M 1.01B 77.64M 75.92M 3.24B | 2.35B 24.54M 21.4M 20.21M 18.35M 34.38M 34.52M 242M 93.4M 1.2B 92.18M 90.14M 3.85B |
| Net income | 267M 2.78M 2.43M 2.29M 2.08M 3.9M 3.91M 27.44M 10.59M 136M 10.45M 10.22M 437M | 302M 3.14M 2.74M 2.59M 2.35M 4.4M 4.42M 31.01M 11.97M 153M 11.81M 11.55M 493M |
| Net Debt | -99.42M -1.04M -903K -853K -775K -1.45M -1.46M -10.22M -3.94M -50.54M -3.89M -3.81M -163M | 200M 2.08M 1.81M 1.71M 1.56M 2.92M 2.93M 20.53M 7.92M 102M 7.82M 7.64M 327M |
Employees
236
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | ₹191.45 | +1.47% | 13,725 |
| 26-09-17 | ₹188.67 | -0.08% | 18,618 |
| 26-09-16 | ₹188.82 | -0.73% | 9,185 |
| 26-09-15 | ₹190.20 | +2.27% | 28,652 |
| 26-09-11 | ₹185.97 | +0.51% | 22,611 |
- Stock Market
- Stocks
- KILITCH Stock
- KILITCH Stock
Select your edition
All financial news and data tailored to specific country editions

















